Open AccessActivity of novel antifungal compound APX001A against a large collection of Candida auris
Author(s) -
Elizabeth L. Berkow,
Shawn R. Lockhart
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky302
Subject(s) - candida auris , microbiology and biotechnology , broth microdilution , fungal pathogen , antifungal , biology , pathogen , aspergillus , fungi imperfecti , antimicrobial , minimum inhibitory concentration
APX001A is an antifungal agent that targets a novel pathway-glycosylphosphatidylinositol glycolipid biosynthesis. It has been shown to be effective against a variety of fungal species, including Candida spp., Aspergillus spp. and other filamentous fungi.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom